TTI.V · Thiogenesis Therapeutics, Corp.
Canada · RS rating 26 · As of 2026-10-14
| Price | 0.50 CAD |
|---|---|
| 1-day change | -9.1% |
| RS rating (overall / 1M / 3M / 12M) | 26 / 61 / 24 / 21 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 19 / 12 |
| Industry group (rank) | Medical-Biomed/Biotech (54) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +35.1% |
| Market cap (USD) | $26.1M |